A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too.As per DelveInsight, the total prevalent population of Duchenne Muscular Dystrophy in the 7MM was found to be 31,386, whereas, total diagnosed prevalent population was found to be 26,678 in 2017.The newsletter will help the readers and clients to gain a perspective on the latest trends in the Duchenne Muscular Dystrophy Market, its epidemiology and the role of mutations that form the underlying cause of the disease.The newsletter presents a glimpse of the detailed report DelveInsight hosts in its vast repository of the pharma market research reports with the pipeline activity, key companies developing drugs, research and innovative approaches in the field, and latest collaborations, and licensing deals on the news front.Download the newsletter by filling up an easy form to the right and subscribe to our emailer list for more such bespoke insights delivered right into your inbox.Stay in touch for more.

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too. As per DelveInsight, the total prevalent population of Duchenne Muscular Dystrophy in the 7MM was found to be 31,386, whereas, total diagnosed prevalent population was found to be 26,678 in 2017. The newsletter will help the readers and clients to gain a perspective on the latest trends in the Duchenne Muscular Dystrophy Market, its epidemiology and the role of mutations that form the underlying cause of the disease. The newsletter presents a glimpse of the detailed report DelveInsight hosts in its vast repository of the pharma market research reports with the pipeline activity, key companies...

Duchenne Muscular Dystrophy

Download the Duchenne Muscular Dystrophy(DMD)newsletter by filling up an easy form to the right and subscribe to our emailer list for more such bespoke insights delivered right into your inbox.